Home LiteratureArticle Details
PMID: 475520 Published · ppublish English Case Reports Journal Article

Serious staphylococcal infections with strains tolerant to bactericidal antibiotics.

Archives of internal medicine ·Vol. 139 ·No. 9 ·1979-09-00 ·Pages 1026-31

Denny AE, Peterson LR, Gerding DN, Hall WH

Abstract

The clinical response in 20 cases of serious staphylococcal infection was compared with the in vitro resistance or "tolerance" of the infecting Staphylococcus to killing by antibiotics used in treatment. Cases were divided into two groups: (1) patients who initially received nonbactericidal antibiotics (ten cases), and (2) patients who initially received bactericidal antibiotics with or without nonbactericidal antibiotics. Mortality due to uncontrolled staphylococcal infection was 40% (4/10) in group 1 as compared with no mortality (1/10) in group0) in group 1 as compared with no mortality (0/10) in group 2. The duration of positive cultures after start of therapy in group 1 (mean, 6.1 days) was significantly longer than that in group 2 (mean, 1.3 days). The duration of fever after start of therapy in group 1 was not significantly different when compared with group 2.

MeSH Terms
Adult Aged Anti-Bacterial Agents/pharmacology,therapeutic use Drug Resistance, Microbial Female Humans Male Microbial Sensitivity Tests Middle Aged Staphylococcal Infections/drug therapy,mortality Staphylococcus aureus/drug effects
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Denny A E
Peterson L R
Gerding D N
Hall W H
Article Info
Journal
Archives of internal medicine
Abbr.
Arch Intern Med
ISSN
0003-9926
Published
1979-09-00
Pages
1026-31
Language
English
Region
United States
NLM ID
0372440
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]